Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers develop new viral vectored poultry vaccine
MD and IBD are both highly infectious diseases and associated with high mortality rates.
Development could lead to vaccines that target multiple avian diseases 

A new recombinant vaccine that is effective against Marek’s disease (MD) and infectious bursal disease (IBD) has been developed by researchers at the Pirbright Institute.

Most poultry vaccines use a modified herpesvirus of turkeys (HVT) to induce protection against poultry diseases, including MD and IDB. When used alone, these vaccines are highly effective. However, they often fail to activate sufficient immune responses when combined with other HVT vaccines.

The new vaccine uses a viral vector called SB-1, which has a long history of working as a combined vaccine with HVT. By genetically modifying the SB-1 strain, the team at Pirbright were able to insert protective genes from the IBD virus and confirm that the resulting virus could provide immunity against both diseases.

Writing in npj Vaccines, the researchers show the vaccine could provide immunity against IBDV infection at the same level as HVT vectored vaccines. With further advantage of complementing HVT vectored vaccines, the new SB-1 vector offers potential for developing commercial vaccines capable of giving simultaneous protection against multiple avian diseases.

“This development allows us to engineer vaccines that target multiple diseases which complement existing commercial vaccines,” explained Professor Venu Nair, head of the Viral Oncogenesis group. “The technique also offers scope for us to include other virus genes such as from avian influenza and Newcastle disease in the SB-1 vaccine, enabling us to protect against even more diseases in a single dose”.

MD and IBD are both highly infectious diseases and associated with high mortality rates. As such, they remain a constant threat to the productivity if the worldwide poultry industry. 

Become a member or log in to add this story to your CPD history

RCVS announces 1CPD app update

News Story 1
 The RCVS has announced a new version of its 1CPD mobile app, with enhanced features for veterinary surgeons and veterinary nurses to record their continuing professional development.

The mobile app includes a new 'what would you like to do?' shortcut for frequent tasks, a notification badge, and the ability to scan a QR code from the home screen to easily record an activity.

Users will be prompted to update the app from the App Store or Google Play the next time they log in. For more information, visit RCVS.org.uk 

Click here for more...
News Shorts
Nominations open for RCVS and VN Council elections

The nomination period for the 2026 RCVS Council and VN Council elections is now open, with three veterinary surgeon seats and two veterinary nurse seats available.

Prospective candidates can download an information pack and nomination form from the RCVS website. Individuals can nominate themselves for the elections, with the results to be announced in the spring.

Clare Paget, the recently appointed RCVS Registrar and elections returning officer, said: "If you want to play your part in influencing and moulding how the professions are regulated, and making key decisions on matters of great importance to your peers, the public and animal health and welfare, please consider standing for RCVS Council or VN Council next year."

Nominations close at 5pm on Saturday, 31 January 2026.